STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: Diamyd Medical AB (STO:DIAMB) (www.omxgroup.com, ticker: DIAM B; www.otcqx.com, ticker DMYDY) Diamyd Medical announced today that the Board of Directors has appointed Elisabeth Lindner as President and CEO for the Company.
